EP2250279
And-IFNAR1 mótefni með minni Fc bindilsækni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.2.2009EP published:
13.4.2016EP application number:
09707396.9
EP translation filed:
11.7.2016Grant published:
15.8.2016EPO information:
European Patent Register
Max expiry date:
5.2.2029Expiry date:
5.2.2027Next due date:
28.2.2027
Title:
ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY
Timeline
Today
6.2.2009EP application
13.4.2016EP Publication
11.7.2016Translation submitted
15.8.2016Registration published
5.2.2027Expires
Owner
Name:
AstraZeneca ABAddress:
SE-151 85, , Södertälje, SE
Inventor
Name:
COYLE, AnthonyAddress:
WashingtonDC, US
Name:
KIENER, PeterAddress:
PotomacMD, US
Name:
WU, HerrenAddress:
BoydsMD, US
Name:
CIBOTTI, RicardoAddress:
BethesdaMD, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
6962 PDate:
8.2.2008Country:
US
Number:
34618 PDate:
7.3.2008Country:
US
Number:
49970 PDate:
2.5.2008Country:
US
Classification
Categories:
C07K 16/28, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 9.1.2017
Expires: 5.2.2018
Payer: Árnason Faktor
Number: 10
Paid: 8.1.2018
Expires: 5.2.2019
Payer: Árnason Faktor
Number: 11
Paid: 9.1.2019
Expires: 5.2.2020
Payer: Árnason Faktor
Number: 12
Paid: 14.1.2020
Expires: 5.2.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 12.1.2021
Expires: 5.2.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 5.1.2022
Expires: 5.2.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 5.1.2023
Expires: 5.2.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 5.1.2023
Expires: 5.2.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 9.1.2024
Expires: 5.2.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 24.1.2025
Expires: 5.2.2026
Payer: Árnason Faktor ehf.
Number: 18
Paid: 4.2.2026
Expires: 5.2.2027
Payer: Árnason Faktor ehf.